KRISTIN FINKE: Open Payments
NPI 1598003824 · PALATINE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 44 payments from 10 companies in 2025. Trend: 2023 $268 · 2024 $870 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $342 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $172 |
| Janssen Biotech, Inc. | 7 | $159 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $73 |
| Ipsen Biopharmaceuticals, Inc | 2 | $65 |
| Celltrion USA Inc. | 2 | $50 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| GENZYME CORPORATION | 1 | $35 |
| Lilly USA, LLC | 1 | $32 |
| Ardelyx, Inc. | 1 | $21 |
Products named: RINVOQ, TREMFYA, ENTYVIO, SKYRIZI, XIFAXAN, IQIRVO, VEGZELMA, VOQUEZNA.
Industry payments across IL — which companies pay providers there.
